Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1134440

registered interest
date	25/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cataracts: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the average cost to the NHS is of carrying out a cataract operation.
tabling member constituency	Tewkesbury
tabling member printed	Mr Laurence Robertson
uin	268959
answer	answer is ministerial correction date of answer 01/07/2019 answer text <p>Latest published data – for 2017-18 – shows that the average unit cost to the National Health Service of carrying out a cataract operation is £803.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 01/07/2019 15:37:02 answering member 1585 label Biography information for Stephen Hammond
tabling member	253 label Biography information for Mr Laurence Robertson

1134491

registered interest
date	25/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect on the provision of healthcare for UK citizens in the EU of the UK leaving the EU without a deal.
tabling member constituency	Upper Bann
tabling member printed	David Simpson
uin	269017
answer	answer is ministerial correction date of answer 03/07/2019 answer text <p>Under current European Union-based entitlements, the United Kingdom pays for the healthcare costs of 180,000 UK nationals, mostly pensioners, in health systems across the EU. There are around 50 million UK tourist visits to the EU annually; the European Healthcare Insurance Card (EHIC) is used in around 0.5% of these visits. Moreover, approximately 50,000 posted workers are protected through the current arrangements.</p><p>The UK Government has proposed to EU Member States that, in a no-deal scenario, we should maintain the existing healthcare arrangements until 31 December 2020, with the aim of minimising disruption to UK nationals’ and EU citizens’ healthcare provision. The UK Government is working to put in place bilateral agreements with Member States to protect existing healthcare arrangements for UK nationals beyond exit day. For UK nationals that live in EU Member States, the UK cannot unilaterally guarantee the continuation of current arrangements, as this depends on decisions by Member States.</p><p>EU Member States such as Spain have made public commitments that they will enable resident UK nationals and visitors to access healthcare in the same way they do now, and we hope to reach such agreements with all Member States.</p><p>Although we are hopeful that we can agree reciprocal healthcare arrangements, as a responsible Government we have developed a multi-layered approach to minimise disruption to healthcare provision to UK nationals currently in or travelling to the EU Member States.</p><p>The UK Government has committed to fund healthcare for UK nationals (and others for whom the UK is responsible) who have applied for, or are undergoing, treatments in the EU prior to and on exit day, for up to one year, to protect the most vulnerable.</p><p>Individuals are always responsible for ensuring they have sufficient healthcare insurance. Anyone who is living, working or studying in EU Member States should check the country specific guidance on GOV.UK and NHS.UK for updates.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 03/07/2019 15:33:20 answering member 1585 label Biography information for Stephen Hammond
tabling member	1597 label Biography information for David Simpson

1134036

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the availablity of (a) critical and (b) short shelf-life medicines in the event of the UK leaving the EU without a deal.
tabling member constituency	Coatbridge, Chryston and Bellshill
tabling member printed	Hugh Gaffney
uin	268516
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>The Government fully understands that maintaining access to all medicines and medical products, including critical medicines and short shelf-life products, is vitally important to millions of people in this country. Ensuring unhindered supply of these products remains the Government’s top priority.</p><p> </p><p>As in preparation for 29 March and 12 April, our ‘no deal’ EU Exit contingency plans for 31 October will cover the NHS, social care and the independent sector and covers all medicines, medical devices and clinical consumables, supplies for clinical trials, vaccines and countermeasures, and organs and tissues for transplants.</p><p>The Department has continued to work closely with the Devolved Administrations, industry trade bodies and suppliers, the NHS and other key stakeholders. Prior to 29 March, the Department analysed the supply chains of 12,300 medicines, close to half a million product lines of medical devices and clinical consumables, vaccines used in national and local programmes, and essential non-clinical goods on which the health and care system relies. These analyses and assessments have been updated where necessary and will continue to be refined while a ‘no deal’ EU Exit remains a possibility. This work has informed our plans.</p><p>We are asking suppliers to analyse their supply chains and to make alternative plans if they anticipate disruption, including rerouting to alternative ports or using airfreight where necessary. Our contingency measures aim to support industry-led measures and, where required, act as a ‘last resort’ to be used only when a supplier’s alternative arrangements encounter difficulties, to ensure uninterrupted supply.</p><p>In the case of medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes, we are working closely with suppliers to make alternative arrangements using airfreight.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>While we never give guarantees, we are confident that, if everyone – including suppliers, freight companies, international partners and the health and care system – does what they need to do, the supply of medicines and medical products should be uninterrupted in the event of a no-deal EU Exit.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 02/07/2019 11:33:39 answering member 1585 label Biography information for Stephen Hammond
tabling member	4614 label Biography information for Hugh Gaffney

1134074

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incontinence: Products
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the continued smooth import and export of continence products and similar medical devices in the event of the UK leaving the EU without a deal; and if he will make a statement.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	268443
answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>As in preparation for 29 March and 12 April, our contingency plans for 31 October will cover the National Health Service, social care and the independent sector and covers all medicines, medical devices and clinical consumables, supplies for clinical trials, vaccines and countermeasures, and organs and tissues for transplants.</p><p>The Department has continued to work closely with the devolved administrations, industry trade bodies and suppliers, the NHS and other key stakeholders. Prior to 29 March, the Department analysed the supply chains of 12,300 medicines, close to half a million product lines of medical devices and clinical consumables, vaccines used in national and local programmes, and essential non-clinical goods on which the health and care system relies. These analyses and assessments have been updated where necessary and will continue to be refined while a ‘no deal’ European Union exit remains a possibility. This work has informed our plans.</p><p>We are asking suppliers to analyse their supply chains and to make alternative plans if they anticipate disruption, including rerouting to alternative ports or using airfreight where necessary. Our contingency measures aim to support industry-led measures and, where required, act as a ‘last resort’ to be used only when a supplier’s alternative arrangements encounter difficulties, to ensure uninterrupted supply.</p><p>While we never give guarantees, we are confident that, if everyone – including suppliers, freight companies, international partners and the health and care system – does what they need to do, the supply of medicines and medical products should be uninterrupted in the event of a ‘no deal’ EU exit.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 27/06/2019 15:10:41 answering member 1585 label Biography information for Stephen Hammond
tabling member	1538 label Biography information for Rosie Cooper

1134075

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what role has recently been played by Deloitte, and at what cost, in the development by NHS Improvement of proposals to introduce a centralised NHS procurement system for products and services; and what steps are being taken to ensure that the introduction of such a system does not lead to a restriction on the freedom of medical practitioners to prescribe any continence product on the Medicines Tariff that they consider to be the most appropriate product for the individual patient.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	268444
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>NHS Improvement, through an open and competitive procurement process, awarded Deloitte a contract to support NHS Improvement to develop a new NHS Procurement Target Operating Model. The contract for phase 1 of this work, which ended on 31 May 2019, cost £400,000.</p><p>The new Procurement Target Operating Model will consider the processes, data, and skills and capabilities to deliver a more efficient procurement service. The remit of the Procurement Target Operating Model programme does not cover clinical products and therefore were not considered as part of this review. NHS Improvement has collaborated with National Health Service providers’ chief executives, finance and procurement leads to develop the NHS’s procurement target operating model. Members of the Healthcare Supply Association have also been engaged with as part of the target operating model’s development.</p><p>Clinical products, including continence products, which are procured by the NHS are the remit of Supply Chain Coordination Limited who work with NHS providers’ procurement teams across England. Clinical product suppliers have not been engaged with on the new procurement target operating model as they are outside the its remit.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 268445 question first answered 02/07/2019 11:24:10 answering member 1585 label Biography information for Stephen Hammond
tabling member	1538 label Biography information for Rosie Cooper

1134076

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incontinence: Products
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the (a) Health Care Supply Association, (b) main trade associations for suppliers of continence products and (c) organisations representing patients who use continence products have been consulted on the development by NHS Improvement of proposals to introduce a centralised NHS procurement system for products and services.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	268445
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>NHS Improvement, through an open and competitive procurement process, awarded Deloitte a contract to support NHS Improvement to develop a new NHS Procurement Target Operating Model. The contract for phase 1 of this work, which ended on 31 May 2019, cost £400,000.</p><p>The new Procurement Target Operating Model will consider the processes, data, and skills and capabilities to deliver a more efficient procurement service. The remit of the Procurement Target Operating Model programme does not cover clinical products and therefore were not considered as part of this review. NHS Improvement has collaborated with National Health Service providers’ chief executives, finance and procurement leads to develop the NHS’s procurement target operating model. Members of the Healthcare Supply Association have also been engaged with as part of the target operating model’s development.</p><p>Clinical products, including continence products, which are procured by the NHS are the remit of Supply Chain Coordination Limited who work with NHS providers’ procurement teams across England. Clinical product suppliers have not been engaged with on the new procurement target operating model as they are outside the its remit.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 268444 question first answered 02/07/2019 11:24:10 answering member 1585 label Biography information for Stephen Hammond
tabling member	1538 label Biography information for Rosie Cooper

1134088

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Construction
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many new NHS hospital facilities specifically for secondary and acute care in England (a) have been built, (b) are under construction and (c) are planned for completion between 2015 and 2025; what the (i) location and (ii) estimated capital value is of each of those new hospital facilities, including those that are valued at less than £100 million; and what the proportion of financing for each project is (A) public and (B) private financing.
tabling member constituency	Walthamstow
tabling member printed	Stella Creasy
uin	268474
answer	answer is ministerial correction date of answer 27/06/2019 answer text <p>In the 2017 Spring and Autumn Budgets, the Government committed £3.9 billion in new capital investment for the National Health Service. £2.4 billion of this has been allocated to over 150 sustainability and transformation partnership (STP) schemes to modernise and transform buildings and services across the country. In the Spending Review later this year, the Government will consider proposals from the NHS for a multi-year capital plan to support the health service as outlined in the NHS Long Term Plan.</p><p> </p><p>Separate from the STP capital programme, the Department has also supported a variety of other investments in new NHS facilities. Under Section 40 of the NHS Act 2006, the Secretary of State may give financial assistance, such as loans or Public Dividend Capital to any NHS foundation trust.</p><p> </p><p>The Papworth Hospital and the Alder Hey Children’s Hospital were completed in 2018 and 2015 respectively under the Private Finance Initiative (PFI). The Royal Liverpool Hospital and Midland Metropolitan Hospital started off as PFI schemes and are now being completed with public capital.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 27/06/2019 12:57:06 answering member 1585 label Biography information for Stephen Hammond
tabling member	4088 label Biography information for Stella Creasy

1134269

registered interest
date	24/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Consultants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many medical consultants were employed by the NHS in each financial year since 2015; and what the ratio was of people becoming consultants compared to the number vacating that position in each of those financial years.
tabling member constituency	Ealing Central and Acton
tabling member printed	Dr Rupa Huq
uin	268625
answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>NHS Digital publishes Hospital and Community Health Services workforce statistics. These include staff working in hospital trusts and clinical commissioning groups (CCGs), but not staff working in primary care or in general practitioner surgeries, local authorities or other providers.</p><p> </p><p> </p><p> </p><p>The following table shows the number of medical consultants who work in National Health Service trusts and CCGs in England as at March each year, full time equivalent.</p><table><tbody><tr><td><p> </p></td><td><p>Number of Medical Consultants</p></td></tr><tr><td><p>March 2015</p></td><td><p>42,100</p></td></tr><tr><td><p>March 2016</p></td><td><p>43,600</p></td></tr><tr><td><p>March 2017</p></td><td><p>45,100</p></td></tr><tr><td><p>March 2018</p></td><td><p>46,600</p></td></tr><tr><td><p>March 2019</p></td><td><p>48,000</p></td></tr></tbody></table><p>Source: NHS Digital workforce statistics</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The following table shows the number of joiners to and leavers from the consultant staff group and the ratio of joiners to leavers, in NHS trusts and CCGs in England, between 31 March 2015 to 31 March 2019, headcount.</p><table><tbody><tr><td><p> </p></td><td><p>Joiners</p></td><td><p>Leavers</p></td><td><p>Ratio of Joiners to Leavers</p></td></tr><tr><td><p>March 2015 - March 2016</p></td><td><p>4,360</p></td><td><p>2,734</p></td><td><p>1.59</p></td></tr><tr><td><p>March 2016 - March 2017</p></td><td><p>4,469</p></td><td><p>2,822</p></td><td><p>1.58</p></td></tr><tr><td><p>March 2017 - March 2018</p></td><td><p>4,678</p></td><td><p>3,014</p></td><td><p>1.55</p></td></tr><tr><td><p>March 2018 - March 2019</p></td><td><p>4,537</p></td><td><p>2,990</p></td><td><p>1.52</p></td></tr></tbody></table><p>Source: NHS Digital workforce statistics</p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 02/07/2019 11:17:06 answering member 1585 label Biography information for Stephen Hammond
tabling member	4511 label Biography information for Dr Rupa Huq

1133843

registered interest
date	21/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance has been issued to clinical commissioning groups on restricting access to operations until a person's medical condition worsens; and if he will make a statement.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	267717
answer	answer is ministerial correction date of answer 26/06/2019 answer text <p>It is for the local clinical commissioning group (CCG) to decide what services they commission for the people they are responsible for – this will mean making clinical judgements about the effectiveness and value of treatments, and the best allocation of resources. CCGs do this based on the healthcare needs of their local populations and clinical evidence, to ensure they are providing the best possible, sustainable care for their patients.</p><p> </p><p>Treatment decisions should always be made by doctors based on a patient’s individual clinical needs and informed by the National Institute for Health and Care Excellence’s (NICE) guidelines.</p><p> </p><p>NICE clinical guidelines make many recommendations spanning all stages of care from diagnosis to treatment of a condition. They represent best practice and are based on available evidence and developed through consultation. Health professionals and organisations are expected to take the guidance fully into account when deciding treatments.</p><p> </p><p>A fundamental principle of the National Health Service is that, for people who are ‘ordinarily resident’ in the United Kingdom, treatment is free at the point of need, regardless of the patient’s ability to pay. Patient payments, other than those limited forms permitted by Regulations (such as prescription charges, payments for some clinical activity undertaken by dentists, and visitor and migrant charges) are contrary to NHS policy.</p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 267718 question first answered 26/06/2019 15:37:04 answering member 1585 label Biography information for Stephen Hammond
tabling member	432 label Biography information for Helen Jones

1133844

registered interest
date	21/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgery: Private Sector
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance has been issued to NHS Trusts on charging for operations which were previously offered free on the NHS.
tabling member constituency	Warrington North
tabling member printed	Helen Jones
uin	267718
answer	answer is ministerial correction date of answer 26/06/2019 answer text <p>It is for the local clinical commissioning group (CCG) to decide what services they commission for the people they are responsible for – this will mean making clinical judgements about the effectiveness and value of treatments, and the best allocation of resources. CCGs do this based on the healthcare needs of their local populations and clinical evidence, to ensure they are providing the best possible, sustainable care for their patients.</p><p> </p><p>Treatment decisions should always be made by doctors based on a patient’s individual clinical needs and informed by the National Institute for Health and Care Excellence’s (NICE) guidelines.</p><p> </p><p>NICE clinical guidelines make many recommendations spanning all stages of care from diagnosis to treatment of a condition. They represent best practice and are based on available evidence and developed through consultation. Health professionals and organisations are expected to take the guidance fully into account when deciding treatments.</p><p> </p><p>A fundamental principle of the National Health Service is that, for people who are ‘ordinarily resident’ in the United Kingdom, treatment is free at the point of need, regardless of the patient’s ability to pay. Patient payments, other than those limited forms permitted by Regulations (such as prescription charges, payments for some clinical activity undertaken by dentists, and visitor and migrant charges) are contrary to NHS policy.</p><p> </p><p> </p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 267717 question first answered 26/06/2019 15:37:04 answering member 1585 label Biography information for Stephen Hammond
tabling member	432 label Biography information for Helen Jones